Fusion Pharmaceuticals Inc. (FUSN) has 20 open-market insider trades by 10 insiders since 2020. The most active filer is John Valliant, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Chau Quang Khuong | Dir | — | 1 | $15.3M | 2022-11-11 |
| & Johnson Johnson | 10% Owner | — | 1 | $12.3M | 2020-06-30 |
| David Bonderman | — | — | 1 | $4.3M | 2020-06-30 |
| Johan Christenson | Dir | — | 1 | $4.1M | 2020-06-30 |
| John Valliant | CEO | — | 7 | $1.2M | 2024-06-04 |
| Steven Gannon | Dir | — | 4 | $277K | 2024-06-04 |
| Heather Preston | Dir | — | 1 | $150K | 2020-06-30 |
| John J. Crowley | CFO | — | 1 | $111K | 2024-06-04 |
| ADAMS Street Partners LLC | 10% | — | 2 | $103K | 2020-12-24 |
| James J. O'Leary | Chief Medical Officer | — | 1 | $5K | 2021-08-31 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Steven Gannon | Director | Buy | $180K | 2022-08-11 |
| John Valliant | CEO | Sell | $53K | 2022-04-25 |
| John Valliant | CEO | Sell | $8K | 2022-04-20 |
| John Valliant | CEO | Sell | $432K | 2022-04-11 |
| John Valliant | CEO | Sell | $16K | 2022-04-06 |
| John Valliant | CEO | Sell | $29K | 2022-04-01 |
Companies that share insiders with FUSN, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| John Valliant | CEO | Sell | $2K | 2022-03-30 |
| John Valliant | CEO | Sell | $78K | 2022-03-25 |
| John Valliant | CEO | Sell | $36K | 2022-03-21 |
| John Valliant | CEO | Sell | $27K | 2022-03-17 |
| John Valliant | CEO | Sell | $10K | 2022-03-14 |
| John Valliant | CEO | Sell | $20K | 2022-03-09 |
| John Valliant | CEO | Sell | $104K | 2022-03-04 |
| John Valliant | CEO | Sell | $403K | 2022-03-01 |
| John Valliant | CEO | Sell | $165K | 2022-02-24 |